Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Proton Pump Inhibitors | 2 | 2020 | 377 | 1.18 | Why? |
| Stomach Diseases | 1 | 2020 | 27 | 0.85 | Why? |
| Phthalic Acids | 1 | 2018 | 40 | 0.73 | Why? |
| Spinal Cord Compression | 1 | 2018 | 35 | 0.72 | Why? |
| Hypersensitivity | 2 | 2019 | 1137 | 0.70 | Why? |
| Chromosome Duplication | 1 | 2017 | 6 | 0.70 | Why? |
| Methyl-CpG-Binding Protein 2 | 1 | 2017 | 12 | 0.70 | Why? |
| Rett Syndrome | 1 | 2017 | 9 | 0.70 | Why? |
| Metals, Heavy | 1 | 2019 | 147 | 0.67 | Why? |
| Mediastinal Neoplasms | 1 | 2018 | 57 | 0.67 | Why? |
| Rhinitis, Allergic | 3 | 2020 | 704 | 0.67 | Why? |
| Atrial Function, Left | 1 | 2018 | 82 | 0.66 | Why? |
| Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 106 | 0.65 | Why? |
| Albuterol | 1 | 2017 | 105 | 0.65 | Why? |
| Chromosomes, Human, X | 1 | 2017 | 81 | 0.65 | Why? |
| Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 56 | 0.65 | Why? |
| Republic of Korea | 9 | 2021 | 5858 | 0.60 | Why? |
| Hepatitis B Vaccines | 1 | 2018 | 245 | 0.60 | Why? |
| Olfactory Mucosa | 1 | 2018 | 372 | 0.58 | Why? |
| Heart Atria | 1 | 2018 | 267 | 0.57 | Why? |
| Air Travel | 1 | 2020 | 585 | 0.51 | Why? |
| Travel-Related Illness | 1 | 2020 | 1357 | 0.48 | Why? |
| Nasal Cavity | 1 | 2018 | 909 | 0.48 | Why? |
| Urticaria | 1 | 2018 | 472 | 0.46 | Why? |
| Bronchodilator Agents | 1 | 2017 | 444 | 0.46 | Why? |
| Lipids | 1 | 2018 | 1079 | 0.44 | Why? |
| Hepatitis B | 1 | 2018 | 888 | 0.39 | Why? |
| Ventricular Function, Left | 1 | 2018 | 1555 | 0.37 | Why? |
| Cardiomyopathies | 1 | 2018 | 997 | 0.36 | Why? |
| Stroke Volume | 1 | 2018 | 2153 | 0.34 | Why? |
| Environmental Exposure | 1 | 2018 | 1558 | 0.34 | Why? |
| Skin Tests | 2 | 2018 | 229 | 0.33 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 1645 | 0.30 | Why? |
| Echocardiography | 1 | 2018 | 3661 | 0.26 | Why? |
| Mental Disorders | 3 | 2021 | 6742 | 0.26 | Why? |
| Dermatitis, Atopic | 2 | 2020 | 714 | 0.23 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.22 | Why? |
| Retraction of Publication as Topic | 1 | 2020 | 77 | 0.20 | Why? |
| Lead | 1 | 2019 | 94 | 0.18 | Why? |
| Mercury | 1 | 2019 | 95 | 0.18 | Why? |
| Cadmium | 1 | 2019 | 105 | 0.18 | Why? |
| Cytogenetic Analysis | 1 | 2017 | 21 | 0.18 | Why? |
| Maternal Inheritance | 1 | 2017 | 6 | 0.18 | Why? |
| Oscillometry | 1 | 2017 | 50 | 0.17 | Why? |
| Comparative Genomic Hybridization | 1 | 2017 | 33 | 0.17 | Why? |
| X Chromosome Inactivation | 1 | 2017 | 23 | 0.17 | Why? |
| Diastole | 1 | 2018 | 168 | 0.17 | Why? |
| Thoracic Vertebrae | 1 | 2018 | 97 | 0.17 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.16 | Why? |
| Aircraft | 1 | 2020 | 498 | 0.15 | Why? |
| Eczema | 1 | 2019 | 227 | 0.15 | Why? |
| Epidemiologic Studies | 1 | 2018 | 554 | 0.15 | Why? |
| Acute Disease | 2 | 2018 | 6029 | 0.14 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.14 | Why? |
| Cohort Studies | 5 | 2021 | 36005 | 0.14 | Why? |
| Multimorbidity | 1 | 2019 | 703 | 0.13 | Why? |
| National Health Programs | 1 | 2020 | 807 | 0.13 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.13 | Why? |
| Single-Blind Method | 1 | 2017 | 1283 | 0.13 | Why? |
| Severity of Illness Index | 6 | 2020 | 48226 | 0.13 | Why? |
| Male | 12 | 2020 | 367725 | 0.12 | Why? |
| Comorbidity | 3 | 2021 | 34796 | 0.12 | Why? |
| Respiratory Function Tests | 1 | 2019 | 1755 | 0.12 | Why? |
| Propensity Score | 1 | 2020 | 2690 | 0.11 | Why? |
| Allergens | 1 | 2018 | 728 | 0.11 | Why? |
| Child | 5 | 2018 | 70012 | 0.11 | Why? |
| Female | 11 | 2020 | 380317 | 0.11 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2021 | 1261 | 0.11 | Why? |
| Asthma | 2 | 2020 | 4383 | 0.11 | Why? |
| Disease Susceptibility | 2 | 2020 | 4002 | 0.10 | Why? |
| Odds Ratio | 2 | 2020 | 5861 | 0.10 | Why? |
| Enzyme Inhibitors | 1 | 2020 | 1881 | 0.10 | Why? |
| Humans | 19 | 2021 | 930598 | 0.09 | Why? |
| Immunization | 1 | 2018 | 2019 | 0.09 | Why? |
| Lung | 1 | 2017 | 31049 | 0.09 | Why? |
| Risk | 1 | 2020 | 5288 | 0.09 | Why? |
| Diabetes Complications | 1 | 2020 | 2358 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.09 | Why? |
| Health Surveys | 1 | 2019 | 2841 | 0.09 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.08 | Why? |
| Venous Thrombosis | 1 | 2021 | 2739 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.07 | Why? |
| Adult | 6 | 2021 | 244371 | 0.06 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.06 | Why? |
| Middle Aged | 5 | 2020 | 270681 | 0.06 | Why? |
| Schools | 1 | 2018 | 4187 | 0.06 | Why? |
| Socioeconomic Factors | 1 | 2019 | 8495 | 0.06 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.05 | Why? |
| Macrolides | 1 | 2020 | 369 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Pharmacovigilance | 1 | 2021 | 501 | 0.04 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2021 | 694 | 0.04 | Why? |
| Italy | 1 | 2020 | 38444 | 0.04 | Why? |
| Databases, Factual | 2 | 2021 | 6248 | 0.04 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.04 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.03 | Why? |
| Infant | 1 | 2018 | 30274 | 0.03 | Why? |
| Aged | 3 | 2020 | 215776 | 0.03 | Why? |
| Protective Factors | 1 | 2020 | 1720 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2020 | 1475 | 0.03 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.03 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.03 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.03 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Diabetes Mellitus | 2 | 2020 | 8207 | 0.02 | Why? |
| Young Adult | 1 | 2019 | 93724 | 0.02 | Why? |
| World Health Organization | 1 | 2021 | 4213 | 0.02 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.02 | Why? |
| Smoking | 1 | 2020 | 3358 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Retrospective Studies | 1 | 2018 | 105322 | 0.02 | Why? |
| Coronary Artery Disease | 1 | 2020 | 2570 | 0.02 | Why? |
| Information Dissemination | 1 | 2020 | 2986 | 0.02 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.02 | Why? |
| Immunocompromised Host | 1 | 2020 | 5150 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3832 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2020 | 10649 | 0.01 | Why? |
| Obesity | 1 | 2020 | 7388 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Heart Failure | 1 | 2020 | 6638 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
Yon's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(135)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(105)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_